Prime Diagnostics
Prime Diagnostics is a privately held, Valdosta, Georgia-based high-complexity clinical diagnostics laboratory operating two CLIA/COLA/CAP-accredited sites in Georgia and Florida. It serves healthcare providers with proprietary Real-Time PCR multi-pathogen panels and comprehensive blood testing delivered with 24-48 hour turnaround.
- Company typePrivate
- Founded2021
- HeadquartersValdosta, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Prime Diagnostics does
Prime Diagnostics is a Valdosta, Georgia-based high-complexity clinical diagnostics laboratory founded in 2021 that specializes in molecular pathogen testing using Real-Time PCR (RT-PCR) technology. The company operates two accredited laboratories — a headquarters facility in Valdosta, GA and a second site in Lake City, FL — both holding CLIA, COLA, and CAP accreditations plus HIPAA-compliant patient result handling. Its product portfolio centers on seven proprietary multi-pathogen RT-PCR panels (UTI-PDx, UTI-STI-PDx, Respira-PDx, Gastro-PDx, Abx-PDx, Wound-PDx, and Nail-PDx) designed to detect multiple infectious agents from a single patient sample, complemented by a comprehensive blood testing service covering hematology, chemistry, immunology, microbiology, and additional molecular panels, all delivered with a 24-48 hour turnaround time.
The company's go-to-market is a B2B clinical laboratory services model targeting healthcare providers — physicians, clinics, hospitals, and medical practices — primarily in Georgia and Florida. Specimen logistics rely on overnight shipping into the two lab locations, with ordering and results delivered through a dedicated Provider Portal (portal.primedx.us) and account management via a Sales Portal (prime.dxresults.com). Revenue is generated on a transaction basis through in-network insurance reimbursement, with a cash-pay billing option for uninsured patients processed through a third-party billing platform (InboxHealth). The Phlebotomy services capability extends sample collection directly to provider locations, supporting workflow integration.
The company is privately held with no disclosed funding rounds, parent company, or management team details in available sources. Strategic positioning emphasizes rapid turnaround, comprehensive single-facility testing (reducing need for multiple lab referrals), and proprietary resistance-marker detection (Abx-PDx covers 20+ AMR targets) intended to support antibiotic stewardship programs. The current evidence base — two regional labs, a defined but un-disclosed provider customer base, and no public revenue figures — indicates an early-stage operational footprint with directional expansion signals but insufficient quantitative disclosure to assess scale.
Prime Diagnostics firmographics
Firmographics- Name
- Prime Diagnostics
- Legal name
- PRIME DIAGNOSTICS
- Website
- https://primedx.us
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Prime Diagnostics is a privately held, Valdosta, Georgia-based high-complexity clinical diagnostics laboratory operating two CLIA/COLA/CAP-accredited sites in Georgia and Florida. It serves healthcare providers with proprietary Real-Time PCR multi-pathogen panels and comprehensive blood testing delivered with 24-48 hour turnaround.
- Ownership category
- akta.pro rank
Where Prime Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Valdosta
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Prime Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Laboratory Diagnostic Testing Services: Clinical laboratory testing services billed to insurance providers (in-network payer mix) or directly to patients. Services include molecular diagnostics (RT-PCR), blood testing, and various pathogen panels. The company offers cash billing options for uninsured patients with transparent pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Insurance-billed testing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Prime Diagnostics product offering
Product offeringCore offering
Prime Diagnostics is a high-complexity clinical diagnostics laboratory that provides molecular (RT-PCR) pathogen testing and blood testing services to healthcare providers. Its test menu includes UTI, UTI-STI, Respiratory, Gastrointestinal, Wound, Nail, and Antibiotic Stewardship (Abx-PDx) panels, alongside comprehensive hematology and chemistry panels. Samples are processed at its CLIA/COLA/CAP-accredited labs in Georgia and Florida with a 24-48 hour turnaround.
Product overview
Prime Diagnostics is a high-complexity clinical laboratory offering a unified diagnostic testing platform centered on Real-Time PCR technology. The portfolio comprises named diagnostic test panels including UTI-PDx, UTI-STI-PDx, Respira-PDx, Gastro-PDx, Abx-PDx, Wound-PDx, and Nail-PDx—all powered by real-time PCR for simultaneous multi-pathogen detection from single samples. Supporting these molecular tests is a comprehensive blood testing service covering hematology, chemistry, immunology, and infectious disease panels. All tests are processed at the company's CLIA-certified laboratories in Georgia and Florida with a 24-48 hour turnaround time.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 24-48 hour turnaround time from sample receipt to results delivery
- +2 more outcomes
Companies that use Prime Diagnostics
Customer profileSegments2 records
Ideal customer profiles1 record
Prime Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature6 records
Prime Diagnostics partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Prime Diagnostics competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Customer concentration
Prime Diagnostics social profiles
Digital presencePrime Diagnostics compliance and trust
Trust signalCompliance4 records
Prime Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Prime Diagnostics leadership team
Management profileNumber of profiles
Prime Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Prime Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Prime Diagnostics
What does Prime Diagnostics do?
Prime Diagnostics is a high-complexity clinical diagnostics laboratory that provides molecular (RT-PCR) pathogen testing and blood testing services to healthcare providers. Its test menu includes UTI, UTI-STI, Respiratory, Gastrointestinal, Wound, Nail, and Antibiotic Stewardship (Abx-PDx) panels, alongside comprehensive hematology and chemistry panels. Samples are processed at its CLIA/COLA/CAP-accredited labs in Georgia and Florida with a 24-48 hour turnaround.
Is Prime Diagnostics a public or private company?
Prime Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Prime Diagnostics founded?
Prime Diagnostics was founded in 2021. It employs 11 to 50 people.
Where is Prime Diagnostics based?
Prime Diagnostics is headquartered in Valdosta, United States, in the North America region.
How does Prime Diagnostics make money?
One revenue line is on record: laboratory Diagnostic Testing Services.
Does Prime Diagnostics have an API?
No public API is recorded for Prime Diagnostics.